Bioengineering approaches for the pancreatic tumor organoids research and application

T Song, B Kong, R Liu, Y Luo, Y Wang… - Advanced Healthcare …, 2024 - Wiley Online Library
Pancreatic cancer is a highly lethal form of digestive malignancy that poses significant
health risks to individuals worldwide. Chemotherapy‐based comprehensive treatment is the …

[HTML][HTML] KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression

Z Zhang, H Zhang, X Liao, H Tsai - Frontiers in Cell and …, 2023 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. It
has a poor response to conventional therapy and has an extremely poor 5-year survival rate …

Recent Progress on Nanomaterial‐Facilitated Electrochemical Strategies for Cancer Diagnosis

X Yuan, B Lin, T Liu, W Zhang, Z Chu… - Advanced …, 2023 - Wiley Online Library
Cancer is a malignant disease that endangers human life, especially owing to its high fatality
rate; therefore, rapid and accurate early screening is needed to effectively improve the …

[HTML][HTML] Pigs: Large Animal Preclinical Cancer Models

K Joshi, T Katam, A Hegde, J Cheng… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Pigs are playing an increasingly vital role as translational biomedical models for studying
human pathophysiology. The annotation of the pig genome was a huge step forward in …

The application of pancreatic cancer organoids for novel drug discovery

MK Melzer, Y Resheq, F Navaee… - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction Pancreatic ductal adenocarcinoma presents with a dismal prognosis.
Personalized therapy is urgently warranted to overcome the treatment limitations of the 'one …

[HTML][HTML] TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration

MK Melzer, S Schirge, J Gout, F Arnold, D Srinivasan… - BMC biology, 2023 - Springer
Background The reactivation of genetic programs from early development is a common
mechanism for injury-induced organ regeneration. T-box 3 (TBX3) is a member of the T-box …

State-matched organoid models to fight pancreatic cancer

MK Melzer, E Roger, A Kleger - Trends in Cancer, 2022 - cell.com
As one of the deadliest cancers, pancreatic ductal adenocarcinoma (PDAC) requires
sophisticated model systems to dissect disease onset, progression, and therapy resistance …

[HTML][HTML] Protocol to use de-epithelialized porcine urinary bladder as a tissue scaffold for propagation of pancreatic cells

MK Melzer, M Breunig, P Lopatta, M Hohwieler, S Merz… - STAR protocols, 2022 - Elsevier
Ex vivo organ culture can be a useful alternative to in vivo models, which can be time-, labor-
, and cost-intensive. Here we describe a step-by-step protocol to use de-epithelialized …

Organoide als Meilenstein auf dem Weg zur personalisierten Therapie des Urothelkarzinoms: ein systematischer Review

MK Melzer, V Zehe, F Zengerling, F Wezel, C Günes… - Die Urologie, 2022 - Springer
Zusammenfassung Hintergrund Die Therapieoptionen beim lokal fortgeschrittenen und
metastasierten Urothelkarzinom beschränken sich aktuell auf etablierte Chemo-sowie …